
Investigators developed a new method to identify potential treatments for hundreds of diseases by profiling drugs approved by the FDA.

Investigators developed a new method to identify potential treatments for hundreds of diseases by profiling drugs approved by the FDA.

Our third and final episode on physician burnout traces the path towards a solution and ultimately, reformation in the system as a whole.

The treatment met the pre-specified primary endpoint of significantly less weight gain in the ENLIGHTEN-Early trial.

Practice separation is occurring more frequently in medium- and large-sized practice groups and among early- and late-career dermatologists.

Barnesiella was positively associated with the first principal component, and category fluency.

There was an elevated risk of violence perpetration in both men and women with schizophrenia spectrum disorder.

Patients with asthma and bronchiectasis were more likely to have chronic rhinosinusitis than patients without bronchiectasis, according to investigators.

A higher percentages of patients treated with tirzepatide had HbA1c less than 7% versus those treated with placebo (85%-90% versus 34%).

Within the first year of the pandemic, total patients in the emergency department with a violent penetrating injury significantly increased—disproportionately so for people of color.

The treatment was comparable to darbepoetin alfa in treating patients with chronic kidney disease who were not undergoing dialysis.

Cases of the inflammatory heart event occurred 1626 times after an mRNA vaccine dose in US patients from December 2020 to August 2021.

The renowned expert joins to discuss the clinical characteristics, societal burdens, and promising therapy research surrounding the hematologic disease.

Dr. Brown discusses the most common conditions of patients treated for ocular trauma and highlights the range of performed procedures in the ED.

Investigators believe the data highlighted the importance of improving and maintaining adequate sleep duration as a public health target for obesity prevention.


The investigators found 56.7% of nursing home patients and 68.1% had multi-drug resistant organism-positive results at enrollment.

New data from the ECZTRA 6 trial noted improvements in itch, sleep interference, anxiety and more.

The NDA has been assigned standard review with a PDUFA target action date in late November 2022.

The monoclonal antibody is designed to reduce the need for red blood cell transfusions to hemolysis among adults with the rare disease.

The recent FDA approval of the oral JAK inhibitor could change the landscape of atopic dermatitis management.

Experts explain that their analysis clearly lays out how lack of effective regulation and an unchecked profit motive created the opioid epidemic.

Previous contrasting studies found that omalizumab was less effective in reducing exacerbations in obese patients.

No difference was observed between atrial shunt placement and sham in the endpoint of CVD death, non-fatal ischemic stroke at 12 months, and rate of total heart failure events at 24 months.

In commemoration of Wear Red Day, here's a breakdown of how US regions differ in cardiovascular disease burden among women.

A systematic review and meta-analysis from a trio of authors argues against the use of government-mandated non-pharmaceutical interventions to curb a pandemic.

Knowing the symptoms and risk factors of CVD unique to women can aid in awareness and prevention efforts.

Dr. Poornima explores improving engagement in women’s cardiovascular care from both a provider and a patient level.

Cardiovascular disease is the leading cause of death for women.

Women with high social isolation and high loneliness scores had a 13.0% - 27.0% higher risk of incident CVD compared to women with low scores.

Dr. Radhakrishnan discusses both the effects of gender bias and why women don't get screened for heart disease.